The Journal of Allergy and Clinical Immunology
Volume 116, Issue 1 , Pages 127-132 , July 2005

Progression of self-reported symptoms in laboratory animal allergy

  • Leslie Elliott, PhD

      Affiliations

    • From the Department of Epidemiology, University of North Carolina at Chapel Hill
    • Corresponding Author InformationReprint requests: Leslie Elliott, PhD, c/o the Department of Epidemiology, CB-7435, University of North Carolina, Chapel Hill, NC 27599-7435.
  • ,
  • Dick Heederik, PhD

      Affiliations

    • Institute of Risk Assessment Sciences, Utrecht University
  • ,
  • Steve Marshall, PhD

      Affiliations

    • From the Department of Epidemiology, University of North Carolina at Chapel Hill
  • ,
  • David Peden, MD

      Affiliations

    • Center for Asthma and Lung Biology, Chapel Hill
  • ,
  • Dana Loomis, PhD

      Affiliations

    • From the Department of Epidemiology, University of North Carolina at Chapel Hill

Received 2 February 2005 ,Revised 18 March 2005 ,Accepted 29 March 2005.

References 

  1. Bush RK, Stave GM. Laboratory animal allergy: an update. Inst Lab Anim Res J. 2003;44:28–51
  2. Aoyama K, Ueda A, Manda F, Matsushita T, Ueda T, Yamauchi C. Allergy to laboratory animals: an epidemiological study. Br J Ind Med. 1992;49:41–47
  3. Bush RK. Mechanism and epidemiology of laboratory animal allergy. Inst Lab Anim Res J. 2001;42:4–11
  4. Wood RA. Laboratory animal allergens. Inst Lab Anim Res J. 2001;42:12–16
  5. Seward JP. Medical surveillance of allergy in laboratory animal handlers. Inst Lab Anim Res J. 2001;42:47–54
  6. Cockcroft A, Edwards J, McCarthy P, Andersson N. Allergy in laboratory animal workers. Lancet. 1981;1:827–830
  7. Venables KM, Tee RD, Hawkins ER, Gordon DJ, Wale CJ, Farrer NM, et al. Laboratory animal allergy in a pharmaceutical company. Br J Ind Med. 1988;45:660–666
  8. Agrup G, Belin L, Sjostedt L, Skerfving S. Allergy to laboratory animals in laboratory technicians and animalkeepers. Br J Ind Med. 1986;43:192–198
  9. Slovak AJ, Hill RN. Laboratory animal allergy: a clinical survey of an exposed population. Br J Ind Med. 1981;38:38–41
  10. Goodno LE, Stave GM. Primary and secondary allergy to laboratory animals. J Occup Environ Med. 2002;44:1143–1152
  11. Bousquet J, Vignola AM, Demoly P. Links between rhinitis and asthma. Allergy. 2003;58:691–706
  12. Caracta CF. Gender differences in pulmonary disease. Mt Sinai J Med. 2003;70:215–224
  13. Bland SM, Levine MS, Wilson PD, Fox NL, Rivera JC. Occupational allergy to laboratory animals: an epidemiologic study. J Occup Med. 1986;28:1151–1157
  14. Botham PA, Lamb CT, Teasdale EL, Bonner SM, Tomenson JA. Allergy to laboratory animals: a follow up study of its incidence and of the influence of atopy and pre-existing sensitisation on its development. Occup Environ Med. 1995;52:129–133
  15. Cullinan P, Cook A, Gordon S, Nieuwenhuijsen MJ, Tee RD, Venables KM, et al. Allergen exposure, atopy and smoking as determinants of allergy to rats in a cohort of laboratory employees. Eur Respir J. 1999;13:1139–1143
  16. Fisher R, Saunders WB, Murray SJ, Stave GM. Prevention of laboratory animal allergy. J Occup Environ Med. 1998;40:609–613
  17. Fuortes LJ, Weih L, Jones ML, Burmeister LF, Thorne PS, Pollen S, et al. Epidemiologic assessment of laboratory animal allergy among university employees. Am J Ind Med. 1996;29:67–74
  18. Heederik D, Venables KM, Malmberg P, Hollander A, Karlsson A-S, Renstrom A, et al. Exposure-response relationships for work-related sensitization in workers exposed to rat urinary allergens: results from a pooled study. J Allergy Clin Immunol. 1999;103:678–684

 Dr Elliott was supported by training grant no. T42/CCT422952 from the National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention. Dr Elliott also worked as a consultant to GlaxoSmithKline, Inc.Dr Peden was supported by grant no. R01 HL62624, “Endotoxin and bronchial inflammation in asthma.”Disclosure of potential conflict of interest: L. Elliott worked as a consultant for GlaxoSmithKline from 2000-2003. D. Peden has consultant arrangements with GlaxoSmithKline, Novartis, and Genentech. All other authors—none disclosed.

PII: S0091-6749(05)00699-8

doi: 10.1016/j.jaci.2005.03.038

The Journal of Allergy and Clinical Immunology
Volume 116, Issue 1 , Pages 127-132 , July 2005